Ballentine Partners, LLC Haleon PLC Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q4 2024
A detailed history of Ballentine Partners, LLC transactions in Haleon PLC stock. As of the latest transaction made, Ballentine Partners, LLC holds 26,961 shares of HLN stock, worth $277,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,961
Previous 22,831
18.09%
Holding current value
$277,428
Previous $241,000
6.64%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HLN
# of Institutions
662Shares Held
432MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.84 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$338 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$248 Million1.6% of portfolio
-
Wellington Management Group LLP Boston, MA15.3MShares$158 Million0.03% of portfolio
-
Morgan Stanley New York, NY9.89MShares$102 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $47.5B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...